GTP Nano (part of GTP Bioways)

We are unique in our ability to develop agile solutions for challenging projects such as the production of difficult-to-express proteins, the development of atypical purification schemes or the formulation of nano-enabled products (NEP). We are very proud of our teams of seasoned and highly qualified professionals and their extensive technical experience across all stages of the biopharmaceutical value chain, from R&D to cGMP production including aseptic filling. We are proud to say that our customers praise our synergic approach. Former Pierre Fabre CDMO facility at St-Julien-en-Genevois becomes GTP Biologics, operated by VBI Therapeutics through a strategic partnership with Fareva. GTP Bioways expands its analytical service provision and provide additional support to biopharmaceutical companies. GTP Bioways is a customer-centric and science-driven CDMO committed to offering uniquely customised process development and GMP manufacturing services for biologics, antibody-drug conjugates and nanodrugs. Drawing on its expertise in solving difficult client problems, our team strives to offer a tailored approach, finely tuned to overcome your specific challenges. Infusing a client-first corporate culture is a major priority of GTP Bioways’ management.